Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Ekso Bionics Holdings, Inc. (NASDAQ: EKSO).

Full DD Report for EKSO

You must become a subscriber to view this report.


Recent News from (NASDAQ: EKSO)

Ekso Bionics® Secures Purchase Orders for the EksoVest(TM) from Two Global Aerospace Manufacturers
Aerospace Industry Leaders Piloting Wearable Exoskeleton to Enhance Worker Safety, and Reduce Fatigue and Risk of Injury on Assembly Production Lines of Commercial and Defense Airplanes RICHMOND, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an i...
Source: GlobeNewswire
Date: December, 10 2018 08:00
Worldwide Adoption of Ekso Bionics® EksoGT(TM) Exoskeleton Allows Stroke and Spinal Cord Injury Patients to Take 100 Million Steps to Date
More than 240 leading rehabilitation centers in over 30 countries helped their patients walk 50,000 miles in the EksoGT exoskeleton during rehab sessions — the distance of walking around the world twice RICHMOND, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Ekso Bio...
Source: GlobeNewswire
Date: December, 04 2018 09:00
Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q3 2018 Results - Earnings Call Transcript
Ekso Bionics Holdings, Inc. (EKSO) Q3 2018 Earnings Conference Call November 07, 2018, 16:30 ET Executives David Carey - Lazar Partners Jack Peurach - President, CEO & Director John Glenn - CFO & Secretary Analysts Bruce Nudell - SunTrust Robinson Humphrey Presen...
Source: SeekingAlpha
Date: November, 07 2018 20:23
Ekso Bionics Holdings misses by $0.02, misses on revenue
Ekso Bionics Holdings (NASDAQ: EKSO ): Q3 GAAP EPS of -$0.11 misses by $0.02 . More news on: Ekso Bionics Holdings, Inc., Earnings news and commentary, , Read more ...
Source: SeekingAlpha
Date: November, 07 2018 16:12
Ekso Bionics Reports Third Quarter 2018 Results
RICHMOND, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended September 30, 2018. Recent Highlights and Accomplishme...
Source: GlobeNewswire
Date: November, 07 2018 16:05
Ekso Bionics Appoints Thomas Schreck to its Board of Directors
RICHMOND, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:  EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced the appointment of Thomas Schreck to its Board of Directors, effective immediately. “W...
Source: GlobeNewswire
Date: November, 06 2018 08:00
Ekso Bionics® to Report Third Quarter 2018 Financial Results on November 7, 2018
RICHMOND, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the third quarter 2018 after the close of trad...
Source: GlobeNewswire
Date: October, 31 2018 08:00
Analysis: Positioning to Benefit within Evolent Health, Scorpio Tankers, Pretium Resources, B2Gold, NACCO Industries, and Ekso Bionics - Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, Aug. 22, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Evolent Health, Inc (NYSE:EVH), Scorpio Tankers Inc. (NYSE:STNG), Pretium...
Source: GlobeNewswire
Date: August, 22 2018 08:30
Premarket Losers as of 9:05 am (8/21/2018)
SEAC -46%  on reporting preliminary Q2 results. More news on: SeaChange International, Inc., J. Jill Group, Inc., First Trust New Opportunities MLP & Energy Fund, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: August, 21 2018 09:10
With Overhang Gone, BTCY Could Generate Triple Digit Returns for Shareholders
Ekso Bionics (EKSO) shares traded from$1.80 to $3.00 in the past 30 days based on commercial success and the potential for a substantial bump in revenue soon. Investors recently long EKSO have made 65% with more potential upside to come. Tandem Diabetes Care, Inc. (TNDM) has traded f...
Source: ACCESSWIRE IA
Date: August, 20 2018 07:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-101.851.811.88841.745527,663
2018-12-071.821.771.831.75156,241
2018-12-061.801.801.841.79151,154
2018-12-041.891.861.921.83104,505
2018-12-031.891.901.93051.81245,437

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-10108,216183,67258.9181Short
2018-12-0711,19445,53524.5833Cover
2018-12-0611,96844,34026.9914Cover
2018-12-0421,72331,01370.0448Short
2018-12-0338,69892,09142.0215Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on EKSO.


About Ekso Bionics Holdings, Inc. (NASDAQ: EKSO)

Logo for Ekso Bionics Holdings, Inc. (NASDAQ: EKSO)

Ekso Bionics is pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. The company s first commercially available product called Ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. By designing and creating some of the most forward thinking and innovative solutions for people looking to augment human capabilities, Ekso Bionics is helping people rethink current physical limitations and achieve the remarkable.

 

 

 

Current Management

  • Thomas Looby / President, Interim CEO
  • Russ Angold / President, Subsidiary, Founder
  • Max SchederBieschin / CFO
  • Ofhir Agmon / Controller
  • Christopher Tagatac / IR
  • Steven Sherman / Chairman
  • David Daniel Boren /
  • Marilyn Hamilton /
  • Jack Peurach /
  • Stanley Stern /
  • Amy Wendell /

Current Share Structure

  • Market Cap: $110,211,477 - 03/09/2018
  • Authorized: 71,428,571 - 03/01/2018
  • Issue and Outstanding: 60,224,851 - 03/01/2018

 


Recent Filings from (NASDAQ: EKSO)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 07 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 07 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 07 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 07 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 30 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 30 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: April, 19 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: April, 19 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 28 2018

 

 


Daily Technical Chart for (NASDAQ: EKSO)

Daily Technical Chart for (NASDAQ: EKSO)


Stay tuned for daily updates and more on (NASDAQ: EKSO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: EKSO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in EKSO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of EKSO and does not buy, sell, or trade any shares of EKSO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/